전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved188 programs
ADCLimited DatastaleAmgenPhase 2

Blinatumomab and Inotuzumab Ozogamicin (Blinatumomab and Inotuzumab Ozogamicin)

Acute Lymphoblastic Leukemia; Immunotherapy · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#ADC#Phase2#antibody-drug-conjugate#Immunotherapy+1
Trials 1Status Recruiting
CGTLimited DatastaleInstituto de Investigación Biom…Phase 2

CAR-T cells therapy (CAR-T cells therapy)

Refractory B-Cell Lymphoma; B-cell Lymphoma Recurrent · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleThe Sixth Affiliated Hospital o…Phase 1

CAR-T therapy for nectin4-positive malignant solid tumor (CAR-T therapy for nectin4-positive malignant solid tumor)

Nectin4-positive Advanced Malignant Solid Tumor · Nectin4-positive Advanced Malignant Soli

#Nectin4-positiveAdvancedMalignan#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleYake Biotechnology Ltd.Phase 2

CART therapy (CART therapy)

Neuroblastoma (NB); Desmoplastic Small Round Cell Tumor (DSRCT) · Neuroblastoma (NB)

#NeuroblastomaNB#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleZhujiang HospitalPreclinical

AML (CART therapy in Acute myeloid leukemia, CART therapy in Acute myeloid leukemia(AML))

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

CART-19/22 (CART-19/22)

Leukemia, B-cell · Leukemia, B-cell

#LeukemiaB-cell#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CART-HER-2 (CART-HER-2)

Advanced HER-2 Positive Solid Tumors; Chemotherapy Refactory · Advanced HER-2 Positive Solid Tumors

#AdvancedHER-2PositiveSolidTumors#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CART33 cells (CART33 cells)

Relapsed Adult Myeloid Leukemia; Chemotherapy Refractory Adult Myeloid Leukemia · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

CD19 CAR-T cells and CD19 positive feeder T cells (CD19 CAR-T cells and CD19 positive feeder T cells)

Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

CD19 CAR-T cells with CRS suppression technology (CD19 CAR-T cells with CRS suppression technology)

Acute Lymphoblastic Leukemia; CD19 Positive · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleH. Lee Moffitt Cancer Center an…Phase 2

CD19 targeted CAR T Cell Therapy (CD19 targeted CAR T Cell Therapy)

Diffuse Large-Cell Lymphoma; Primary Mediastinal Large B-Cell Lymphoma (PMBCL) · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUnion Hospital, Tongji Medical …Phase 1

CD19/BCMA CAR-T cell therapy (CD19/BCMA CAR-T cell therapy)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

CD19/CD20/BCMA CAR T cells (CD19/CD20/BCMA CAR T cells)

Non-Hodgkin Lymphoma, B-cell · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

CD19/CD20/BCMA CAR-T (CD19/CD20/BCMA CAR-T)

Relapsed; Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

BZE2204 (CD19/CD22/BCMA CAR-T cells, CD19/CD22/BCMA CAR-T cells(BZE2204))

Idiopathic Inflammatory Myopathies(IIM); Immune Thrombocytopenia(ITP) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleLiping DouPhase 2

CD22/CD19 CAR-T cell immunotherapy (CD22/CD19 CAR-T cell immunotherapy)

Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleJuventas Cell Therapy Ltd.Phase 1

CNCT19 CAR-T cell therapy (CNCT19 CAR-T cell therapy)

Autoimmune Hemolytic Anemia; Autologous CD19 CAR-T · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Research …Phase 2

CTLA-4/PD-1 antibodies expressing mesoCAR-T (CTLA-4/PD-1 antibodies expressing mesoCAR-T)

Advanced Solid Tumor · PD-1

#PD-1#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleCaigang LiuPhase 3

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#monoclonal-antibody#Caigang
Trials 1Status Recruiting
AntibodyLimited DatastaleJiangsu HengruiPhase 3

Camrelizumab and Chemotherapy (Camrelizumab and Chemotherapy)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#monoclonal-antibody#Jiangsu
Trials 1Status Recruiting

5 / 10 pages

← PreviousNext →